Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M610700200 on February 20, 2007

J. Biol. Chem., Vol. 282, Issue 17, 12458-12466, April 27, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/17/12458    most recent
M610700200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Velasco, L. F. R.
Right arrow Articles by Neves, F. A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Velasco, L. F. R.
Right arrow Articles by Neves, F. A. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Thyroid Hormone Response Element Organization Dictates the Composition of Active Receptor*

Lara F. R. Velasco{ddagger}1, Marie Togashi{ddagger}§1, Paul G. Walfish, Rutinéia P. Pessanha{ddagger}, Fanny N. Moura{ddagger}, Gustavo B. Barra{ddagger}, Phuong Nguyen§, Rachelle Rebong§, Chaoshen Yuan, Luiz A. Simeoni{ddagger}, Ralff C. J. Ribeiro{dagger}{ddagger}, John D. Baxter§2, Paul Webb§3, and Francisco A. R. Neves{ddagger}4

From the {ddagger}Molecular Pharmacology Laboratory, Department of Pharmaceutical Sciences, School of Health Sciences, University of Brasilia, Brasília, DF, Brazil, the §Diabetes Center and Department of Medicine, University of California, San Francisco, California 94143, and the Department of Medicine, Endocrine Division, Mount Sinai Hospital, University of Toronto Medical School, Toronto, Ontario M5G 1X5, Canada

Thyroid hormone (triiodothyronine, T3) is known to activate transcription by binding heterodimers of thyroid hormone receptors (TRs) and retinoid X receptors (RXRs). RXR-TRs bind to T3 response elements (TREs) composed of direct repeats of the sequence AGGTCA spaced by four nucleotides (DR-4). In other TREs, however, the half-sites can be arranged as inverted palindromes and palindromes (Pal). Here we show that TR homodimers and monomers activate transcription from representative TREs with alternate half-site placements. TRbeta activates transcription more efficiently than TR{alpha} at an inverted palindrome (F2), and this correlates with preferential TRbeta homodimer formation at F2 in vitro. Furthermore, reconstruction of TR transcription complexes in yeast indicates that TRbeta homodimers are active at F2, whereas RXR-TRs are active at DR-4 and Pal. Finally, analysis of TRbeta mutations that block homodimer and/or heterodimer formation reveal TRE-selective requirements for these surfaces in mammalian cells, which suggest that TRbeta homodimers are active at F2, RXR-TRs at DR-4, and TR monomers at Pal. TRbeta requires higher levels of hormone for activation at F2 than other TREs, and this differential effect is abolished by a dimer surface mutation suggesting that it is related to composition of the TR·TRE complex. We propose that interactions of particular TR oligomers with different elements play unappreciated roles in TRE-selective actions of liganded TRs in vivo.


Received for publication, November 17, 2006 , and in revised form, February 15, 2007.

* This work was supported by Brazilian Research Council Grants CNPq/PADCT SBIO 620003/02-2 and CNPq 40.00.43/02-5, National Institutes of Health Grants DK41482, DK51281, and DK61468 (to J. D. B.), Canadian Institutes of Health Operational Grant MOP-49448, The Mount Sinai Hospital Foundation of Toronto and Department of Medicine Research Funds, and The Julius Kuhl and Temmy Latner/Dynacare Family Foundations (to P. G. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Both authors contributed equally to this work.

{dagger} Deceased.

2 Consultant to Karo Bio AB, a biotechnology company with commercial interests in nuclear receptors.

3 To whom correspondence may be addressed. Tel.: 415-476-6789; Fax: 415-564-5813; E-mail: pwebb{at}diabetes.ucsf.edu. 4 To whom correspondence may be addressed: Laboratorio de Farmacologia Molecular, Dept. de Ciências Farmacêuticas, Universidade de Brasília, Caixa Postal 4473, 70919-970, Brasília DF, Brazil. Tel.: 55-61-3072098; Fax: 55-61-3474622; E-mail: chico{at}unb.Br.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
P. Lefebvre, B. Cariou, F. Lien, F. Kuipers, and B. Staels
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Physiol Rev, January 1, 2009; 89(1): 147 - 191.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement